Enrolling Clinical Research Studies

ADHD in Children and Adolescents Aged 4-17

Colorectal Cancer Screening

Constipation in Children 6-17

Eosinophilic Esophagitis (EoE)

Gastroparesis

Major Depressive Disorder with Insomnia

Non-Erosive Gastroesophageal Reflux Disease (NERD)

PTSD

Treatment-resistant Depression (TRD)

Psychiatry
PTSD

PTSD

Living with the aftereffects of COVID-19 can cause PTSD.

If you were hospitalized with a life-threatening COVID-19 infection or have lost a family member to COVID-19 and are experiencing unwanted memories, fear and anxiety, and isolation from family and friends, you may have post-traumatic stress disorder. Learn about the CYPRESS research study of an investigational drug for people with PTSD.

To pre-qualify for this study, you must:

  • Be 18 to 65 years of age
  • Have had PTSD symptoms for at least 6 months prior to this study

All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided.


» Study Details | Apply for the Study

Major Depressive Disorder with Insomnia

Major Depressive Disorder with Insomnia

You may qualify for participation if you:

·        Are 18–74 years of age

·        Have been diagnosed with depression

·        Have taken antidepressants in the past that did not work well for you

·        Are currently taking an antidepressant medication but still have symptoms of depression

·        Have difficulty falling asleep or staying asleep, or do not feel rested the next day


» Study Details | Apply for the Study

Treatment-resistant Depression (TRD)

Treatment-resistant Depression (TRD)

Do you have treatment-resistant depression (TRD)? A clinical research study is now enrolling eligible adults. The purpose of this study is to evaluate the effectiveness, safety, and tolerability of an investigational medication in people with TRD.

You may be eligible to participate if you:

  • Are 18 years of age or older
  • Have been diagnosed with major depressive disorder (MDD)
  • Have not responded to at least 2 different anti-depressant treatments

If interested, additional eligibility criteria will be assessed by the study doctor or staff. The commitment for the study is about 24 weeks.

Qualified patients may receive investigational study drug and some study-required medical care at no cost.

» Study Details | Apply for the Study

ADHD in Children and Adolescents Aged 4-17

ADHD in Children and Adolescents Aged 4-17

Preferred Research Partners is enrolling adolescents with ADHD for a number of clinical study opportunities. Please enter your information to be contacted by a member of our study staff for more information to see if your child may qualify for one of our studies.

» Study Details | Apply for the Study

Endocrinology
Low Testosterone

Low Testosterone

Now enrolling adults with low testosterone for a clinical study in Little Rock.

» Study Details | Apply for the Study

Future Studies
Upcoming Studies for Adults and Children

Upcoming Studies for Adults and Children

If would like to submit your information to be contacted for future study opportunities, click to apply here.

» Study Details | Apply for the Study

Gastroenterology
Constipation in Children 6-17

Constipation in Children 6-17

The SPARK-64 Study is looking to evaluate the effectiveness and safety of an investigational drug to see how well it works for treating constipation in 6- to 17-year-old children.

If a child in your care has been suffering from constipation, they may be eligible to take part in the SPARK-64 Study.

Your child may be eligible to take part in the SPARK-64 Study if they:

  • Have 2 or fewer bowel movements per week, without laxatives
  • Are between 6 and 17 years old
  • Weight more than 39 lbs

» Study Details | Apply for the Study

Colorectal Cancer Screening

Colorectal Cancer Screening

Now enrolling for a clinical research study for Colorectal Cancer Screening.

» Study Details | Apply for the Study

Gastroparesis

Gastroparesis

If you are 18 years of age or older and you . . .

  • Have nausea, especially during or after eating
  • Feel full even after eating only a little
  • Have a feeling of being overly full after eating
  • Experience abdominal pain during or after eating

. . . these could be symptoms of gastroparesis and you may be able to participate in this study.


» Study Details | Apply for the Study

Eosinophilic Esophagitis (EoE)

Eosinophilic Esophagitis (EoE)

If you have been diagnosed with EoE and are struggling with symptoms even while on a stable diet and medication, there may be a clinical trial for you.

Eligible participants must:

  • Have, on average, trouble swallowing food at least twice a week
  • Have a documented diagnosis of EoE
  • Be on a stable diet and medication for EoE
  • Be age 18 to 75 years old

» Study Details | Apply for the Study

Non-Erosive Gastroesophageal Reflux Disease (NERD)

Non-Erosive Gastroesophageal Reflux Disease (NERD)

Do you suffer from symptomatic non-erosive gastroesophageal reflux disease? A clinical trial might be an option for you!

The purpose of this study, which involves research, is to determine whether the investigational drug, vonoprazan, is safe and effective in the potential treatment of symptomatic non-erosive gastroesophageal reflux disease compared to a placebo.

You might qualify to participate if you have been experiencing frequent heartburn over the last six months. You must be at least 18 years old and will need to meet with a physician who is participating in this study to determine if you are fully eligible and if this study is right for you.


» Study Details | Apply for the Study

Powered By RealTime-CTMS Clinical Trial Management System